Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 1/2 Study of BMS-986525 as Monotherapy and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

The purpose of this study is to assess the safety and tolerability of BMS-986525 alone and in combination with Pumitamig in participants with Relapsed/Refracto…

Relapsed/Refractory Small Cell Lung Cancer

Estimated

~$10 – $7,500

Bristol-Myers SquibbNCT07325136